ArticleOncotarget2016

Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.

Hyun Kyung Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.